Arie Belldegrun, MD, FACS
Vice Chairman, Board of Directors
Chairman, Scientific Advisory Board
Cougar Biotechnology, Inc.
Chief, Division of Urologic Oncology
David Geffen School of Medicine at UCLA
Dr. Belldegrun joined Cougar Biotechnology, Inc. in December 2003
as Vice Chairman of the Board of Directors and Chairman of the Scientific
Advisory Board. Dr. Belldegrun is Chief of the Division of Urologic
Oncology and holds the Roy and Carol Doumani Chair in Urologic Oncology
at the David Geffen School of Medicine at the University of California,
Los Angeles (UCLA).
He is also the Founder of Agensys, Inc., a privately held biotechnology
company focused on the development of fully human monoclonal antibodies
to treat solid tumor cancers based on Agensys’ proprietary
targets. Dr. Belldegrun served as founding Chairman of Agensys from
1997-2002 and currently serves on Agensys’ Board of Directors
and as a consultant.
He completed his medical degree at the Hebrew University Hadassah
Medical School in Jerusalem, his post graduate fellowship at the
Weizmann Institute of Science and his residency in Urology at Harvard
Medical School. Prior to UCLA, Dr. Belldegrun was at the National
Cancer Institute/NIH as a research fellow in surgical oncology under
Steven A. Rosenberg, MD, PhD. He is certified by the American Board
of Urology and a Fellow of the American College of Surgeons.
Dr Belldegrun is also on the scientific boards of several biotechnology
and pharmaceutical companies and serves as a reviewer for many medical
journals and granting organizations including the Journal of Urology
and the American Foundation of Urologic Diseases. In addition to
holding several patents, Dr. Belldegrun is the author of several
books on prostate and kidney cancers and has written over 250 scientific
publications with an emphasis on urologic oncology, particularly
kidney, prostate and bladder cancers.
John P. Leonard, MD
Assistant Professor Of Medicine, Weill Medical College of Cornell
Clinical Director, New York-Cornell Center for Lymphoma and Myeloma
John P. Leonard, M.D., is assistant professor of medicine at the
Weill Medical College of Cornell University and clinical director
of the New York – Cornell Center for Lymphoma and Myeloma.
In addition, he is medical director of oncology services and assistant
attending physician at the New York – Weill Cornell Center
of New York Presbyterian Hospital. An expert in hematology and oncology,
Dr. Leonard’s research has been published in numerous medical
journals, and he is a member of the editorial board of the Journal
of Clinical Oncology.
He serves as the non-Hodgkin’s lymphoma working group leader
for the Lymphoma Committee of the Cancer and Leukemia Group B (CALGB),
a multicenter cooperative group of the National Cancer Institute.
His primary research interest is in the development of novel therapeutic
strategies for the treatment of hematologic malignancies. Much of
his work has involved the development of radiolabeled and unlabeled
monoclonal antibodies as therapy for lymphoma, as well as immune-based
and other novel therapies. Dr. Leonard performed his undergraduate
work at Johns Hopkins University and received his medical degree
at the University of Virginia School of Medicine in Charlottesville,
He completed his residency in medicine at the New York Hospital
- Cornell Medical Center and Memorial Sloan-Kettering Cancer Center
in New York, NY. He completed a fellowship in hematology and oncology
at Cornell, and served as the chief medical resident at the New
York Hospital - Cornell Medical Center.
CB7630 Scientific Advisory Board
Eric J. Small, M.D. (Chairman of CB7630 Advisory Board)
Director of Urologic Oncology
University of California, San Francisco
Michael A. Carducci, M.D.
Associate Professor of Oncology and Urology
John Hopkins Medical Institutions
Celestia S. Higano, M.D.
Division of Urology
University of Washington
Philip Kantoff, M.D.
Director, The Lank Center for Genitourinary Oncology
Chief, Division of Solid Tumor Oncology
Professor of Medicine
Harvard Medical School
Charles Ryan, MD
Assistant Clinical Professor, Medicine
Program Member, University of California, San Francisco Comprehensive Cancer Center
Howard I. Scher, M.D.
Chief, Genitourinary Oncology Service
D. Wayne Calloway Chair in Urologic Oncology
Memorial Sloan-Kettering Cancer Center
Matthew R. Smith, MD, PhD
Assistant Professor of Medicine
Massachusetts General Hospital
Nicholas J. Vogelzang, M.D.
Nevada Cancer Institute